Global Cardiovascular Implants Market -Industry Analysis, Size, Share, Trends and Forecast, 2016 – 2022

1
Global Cardiovascular Implants Market -Industry
Analysis, Size, Share, Trends and Forecast, 2016
2022
2
The report on Cardiovascular Implants Market by
drug class (disease modifying anti-rheumatic,
nonsteroidal anti-inflammatory, corticosteroids,
uric acid drugs), disease indication (rheumatoid
arthritis, osteoarthritis, gout, psoriatic
arthritis, ankylosing spondylitis), distribution
channel (hospital, retail, online pharmacy)
trends analysis and forecasts up to 2023 studies
the market sizes, key trends and opportunities in
the main geographies such as North America,
Europe, Asia-Pacific, Rest of the World.
According to the report the Global
Cardiovascular Implants Market is projected to
grow at a CAGR of 6.1 in terms of value over the
period of 2017-2023. The growth in the world
market is primarily driven by significant
contribution by North America (Leading region)
region to this market. Get a Sample Request
https//www.infiniumglobalresearch.com/reports/sam
ple_request/83 CVDs includes coronary artery
diseases (CAD) such as angina and myocardial
infarction (heart attack). Other CVDs are
peripheral arterial disease, stroke, heart
failure, hypertensive heart disease, rheumatic
heart disease, cardiomyopathy, heart arrhythmia,
congenital heart disease, valvular heart disease,
carditis, aortic aneurysms, peripheral artery
disease, and venous thrombosis. There various
treatment options available in the market to
treat these cardiovascular diseases such as drug
therapy (ACE inhibitors, antiarrhythmic, aspirin
therapy, beta- blocker therapy, clot buster
drugs, diuretics, etc.), changing lifestyle
habits, and medical surgeries (stents, coronary
stents, peripheral stents, heart bypass surgery,
pacemakers, implantable cardioverter
defibrillators, and heart transplants). These
implants are lifesaving medium to improve the
patients disease condition and are made of
various materials, which includes metals, alloys,
biomaterials, and polymers. Some of the key
driving factors attributing to the growth of this
include increasing number of patients with
cardiovascular diseases such as hypertension,
heart failures and coronary artery diseases, and
shortage of number of heart donors. In addition,
changing lifestyle, alcohol consumption, growing
obesity and smoking further propelling the
market growth, as these factors increase the bold
glucose and lipid levels, which results
3
in serious cardiovascular diseases. According to
American Heart Association publication, it has
been estimated that in the US alone
approximately 5.5 million people suffered from
heart failure in 2013 and 300,000 die each year
because of heart failure. The market for global
cardiovascular implants was valued at USD 26.1
billion in 2015 and is expected to reach around
USD 39.0 billion by 2023, growing at a CAGR of
5.8 during the forecast period of 2017 to 2023.
However, there are certain restraining factors
which could hamper the growth of the market,
which includes, high-risk nature and high
complication rates associated with considerable
mortality, due to frequent use of implants in
older populations with frequent co-morbidities.
Geographically, North America is leading
contributor to the market and is expected to
retain its position during the forecast period.
Nonetheless, the market for Asia-Pacific region
is expected to grow at a faster rate owing to
increasing prevalence of CVD diseases, growing
awareness among the population, improving
healthcare infrastructure, rise in healthcare
spending, and favorable government policies. Make
an Enquiry https//www.infiniumglobalresearch.com
/reports/enquiry/83 Companies profiled Abbott
Laboratories B-Braun Boston Scientific
Medtronic plc. St. Jude Medical, Inc. C. R. Bard,
Inc. Cook Medical Terumo Corporation Edwards
Lifesciences AMG International.
4
Click the Below Full Report Link
https//www.infiniumglobalresearch.com/healthcare_
medical_devices/cardiovascular_implants_market Re
port Highlights The report delivers a strategic
analysis of the global market for cardiovascular
implants and growth forecast for the period from
2017 2023. The scope of the report includes
competitive analysis of various market players
who are operating in the market, segmental
analysis based on type of implants. It also
covers geographical analysis of the market with
growth forecast for the period of 2017 2023.
The Porters Five Forces analysis and value
chain analysis included in the report provides an
insight into market dynamics and industry
competition. The study also provides information
for recent merger and acquisition deals happened
in the global cardiovascular implants market.
Moreover, the report also includes growth
strategies and entry barriers to be considered
to cater to the exact business opportunities in
this market. Additionally, to aid in strategic
decision making, the report also includes
competitive profiling of leading players, recent
developments in the industry and various
business strategies adopted by them. This report
will help players in global cardiovascular implant
s market to plan and implement their strategies
in different market areas such as emerging
geographies, and new technologies.